Long-term Follow-up Results of CARsgen’s Satri-cel as Sequential Therapy After First-Line Treatment for Gastric Cancer Presented at the 2026 ASCO Annual Meetingby BangkokStyle01/06/2026PR Newswire
ASCO 2026 | CStone Presents Updated Clinical Data for CS2009 (PD-1/VEGF/CTLA-4 Trispecific Antibody), Reinforcing Triple-Target Synergy and Delivering Strong Proof-of-Conceptby BangkokStyle01/06/2026PR Newswire
Calibrite Display Plus HL Receives Apple Approval for Hardware-Level Display Calibrationby BangkokStyle01/06/2026PR Newswire
Traveloka 6.6 Mid Year Sale: Up to S$66 Off Flights, Hotels and Attractions for Singapore Travelersby BangkokStyle01/06/2026PR Newswire
Deloitte appoints Robert Hillard as Asia Pacific Chief Executive Officerby BangkokStyle01/06/2026PR Newswire
BofA Securities Asia Forum Gathers Global Investors Amid Surge in Hedge Funds Allocationsby BangkokStyle01/06/2026PR Newswire
UOB and FPT sign MoU to advance AI, technology transformation and financial innovation opportunitiesby BangkokStyle01/06/2026PR Newswire
Hankook’s Ventus Delivers Unwavering Performance Throughout WRC FORUM8 Rally Japan’s Ever-Changing Conditionsby BangkokStyle01/06/2026PR Newswire
ไฮบริด เทรนนิ่ง: เคล็ดลับสร้างความแข็งแกร่งและฟิตไปพร้อมกันอย่างมีประสิทธิภาพby BangkokStyle01/06/202601/06/2026Lifestyle
MICROIP to Debut “AI Vehicle System Business Group” and Edge AI Innovations at COMPUTEX 2026by BangkokStyle01/06/2026PR Newswire
D3 Bio Presents First-Line Data for Elisrasib (D3S-001) at ASCO 2026; Next-Generation KRAS G12C Inhibitor Shows Landmark Efficacy in Untreated NSCLCby BangkokStyle01/06/2026PR Newswire
Jyong Biotech CEO Outlines FDA Pathway and Global Strategy in PharmaBoardroom Live Interviewby BangkokStyle01/06/2026PR Newswire
ImmVira Reports 100% Complete Response Rate at 9 Months in Bladder Carcinoma in Situ with MVR-T3011 at ASCOby BangkokStyle01/06/2026PR Newswire
2026 ASCO | Innovent Presents Preliminary PoC Data of IBI363 (TAK-928) PD-1/IL-2α-bias bispecific fusion protein) in First-line Advanced NSCLCby BangkokStyle01/06/2026PR Newswire
